Cargando…

Senolytics improve muscle adaptation in old mice

Detalles Bibliográficos
Autores principales:	Dungan, Cory M., Peterson, Charlotte A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085595/ https://www.ncbi.nlm.nih.gov/pubmed/36881388 http://dx.doi.org/10.18632/aging.204578

Ejemplares similares

Senolytic treatment rescues blunted muscle hypertrophy in old mice
por: Dungan, Cory M., et al.
Publicado: (2022)

Deletion of SA β‐Gal+ cells using senolytics improves muscle regeneration in old mice
por: Dungan, Cory M., et al.
Publicado: (2021)

Senolytics reduce coronavirus-related mortality in old mice
por: Camell, Christina D., et al.
Publicado: (2021)

Senolytics Reduce Coronavirus-Related Mortality in Old Mice
por: Camell, Christina
Publicado: (2021)

Targeting anxiety and senescence with senolytics
por: Raffaele, Marco, et al.
Publicado: (2022)

Senolytics Improve Physical Function and Increase Lifespan in Old Age
por: Xu, Ming, et al.
Publicado: (2018)

Senolytics alleviate the degenerative disorders of temporomandibular joint in old age
por: Zhou, Yueying, et al.
Publicado: (2021)

Paradoxes of senolytics
por: Blagosklonny, Mikhail V.
Publicado: (2018)

Senescence and Senolytics: State of the Art on Cellular Senescence, Senolytics, and Healthspan
por: Campisi, Judith
Publicado: (2020)

Acute treadmill exercise discriminately improves the skeletal muscle insulin‐stimulated growth signaling responses in mice lacking REDD1
por: Dungan, Cory M., et al.
Publicado: (2019)

Senolytic treatment with dasatinib and quercetin does not improve overall influenza responses in aged mice
por: Torrance, Blake L., et al.
Publicado: (2023)

Senolytics prevent caveolar Ca(V)3.2‐RyR axis malfunction in old vascular smooth muscle
por: Lin, Jie, et al.
Publicado: (2023)

Muscle memory: myonuclear accretion, maintenance, morphology, and miRNA levels with training and detraining in adult mice
por: Murach, Kevin A., et al.
Publicado: (2020)

Senolytic effect of high intensity interval exercise on human skeletal muscle
por: Jean, Wei-Horng, et al.
Publicado: (2023)

Strategies for senolytic drug discovery
por: Power, Helen, et al.
Publicado: (2023)

Senolytics in the treatment of diabetic retinopathy
por: Hassan, Jannah Waled, et al.
Publicado: (2022)

Satellite Cell Depletion Disrupts Transcriptional Coordination and Muscle Adaptation to Exercise
por: Englund, Davis A, et al.
Publicado: (2020)

Senolytic therapy is neuroprotective and improves functional outcome long-term after traumatic brain injury in mice
por: Wang, Jing, et al.
Publicado: (2023)

Discovery of senolytics using machine learning
por: Smer-Barreto, Vanessa, et al.
Publicado: (2023)

Senolytic elimination of senescent macrophages restores muscle stem cell function in severely dystrophic muscle
por: Liu, Lei, et al.
Publicado: (2022)

Therapeutic Potential of Senolytics in Cardiovascular Disease
por: Dookun, Emily, et al.
Publicado: (2020)

Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice
por: Roos, Carolyn M., et al.
Publicado: (2016)

Senolytics improve bone forming potential of bone marrow mesenchymal stem cells from aged mice
por: Zhou, Yueying, et al.
Publicado: (2021)

Nucleus Type-Specific DNA Methylomics Reveals Epigenetic “Memory” of Prior Adaptation in Skeletal Muscle
por: Wen, Yuan, et al.
Publicado: (2021)

Moving senolytics closer to the clinic in IPF
por: Kramer, Daniel, et al.
Publicado: (2023)

Senolytics and senostatics as adjuvant tumour therapy
por: Short, Susan, et al.
Publicado: (2019)

Senolytic drugs: from discovery to translation
por: Kirkland, J. L., et al.
Publicado: (2020)

Cardiac glycosides are broad-spectrum senolytics
por: Guerrero, Ana, et al.
Publicado: (2019)

SENOLYTIC DRUGS: DISCOVERY, TRANSLATION, AND APPLICATION
por: LeBrasseur, Nathan
Publicado: (2019)

Galactose‐modified duocarmycin prodrugs as senolytics
por: Guerrero, Ana, et al.
Publicado: (2020)

NAD(+), Senolytics, or Pyruvate for Healthy Aging?
por: Zhou, Fang-Qiang
Publicado: (2021)

Senolytics in a Model of Alzheimer's Disease
por: Wang, Ellen, et al.
Publicado: (2021)

Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans
por: Zhu, Yi, et al.
Publicado: (2022)

ORALLY ACTIVE, CLINICALLY TRANSLATABLE SENOLYTICS RESTORE Α-KLOTHO IN MICE AND HUMANS
por: Zhu, Yi, et al.
Publicado: (2022)

Senolytic drugs, dasatinib and quercetin, attenuate adipose tissue inflammation, and ameliorate metabolic function in old age
por: Islam, Md Torikul, et al.
Publicado: (2023)

Reduction of senescent fibro‐adipogenic progenitors in progeria‐aged muscle by senolytics rescues the function of muscle stem cells
por: Liu, Lei, et al.
Publicado: (2022)

Clearance of defective muscle stem cells by senolytics restores myogenesis in myotonic dystrophy type 1
por: Conte, Talita C., et al.
Publicado: (2023)

Impact of senolytic treatment on immunity, aging, and disease
por: Lorenzo, Erica C., et al.
Publicado: (2023)

Identification and characterization of Cardiac Glycosides as senolytic compounds
por: Triana-Martínez, Francisco, et al.
Publicado: (2019)

Senolytics: A Novel Strategy for Neuroprotection in ALS?
por: Maximova, Alexandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gecop5bg9umsjqrr0el0vqa73g